Concepedia

Jing Ouyang

JO

Statistics

Publications

65

Citations

6.7K

H-Index

36

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Chongqing Public Health Medical Center

Brigham and Women's Hospital

Harvard University

Jiangxi Science and Technology Normal University

Jing Ouyang is an author at Dana-Farber Cancer Institute specializing in life sciences, oncology, and medicine.

Publications per year

2001–2024

65

Publications

65

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang et al. · Clinical Cancer Research · 2013 · 839 citations

Medicine, Immunology, Oncology +17

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

Michael R. Green, Scott J. Rodig, Przemysław Juszczyński et al. · Clinical Cancer Research · 2012 · 683 citations

Medicine, Immunology, Oncology +17

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors

Diego O. Croci, Juan P. Cerliani, Tomás Dalotto‐Moreno et al. · Cell · 2014 · 499 citations · Full text

Medicine, Cancer Biology, Oncology +14

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

Medicine, Genetics, Oncology +10

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

Margaretha G.M. Roemer, Robert Redd, Fathima Zumla Cader et al. · Journal of Clinical Oncology · 2018 · 367 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 65